A detailed history of Sabal Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sabal Trust CO holds 22,719 shares of EW stock, worth $1.52 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
22,719
Previous 31,653 28.22%
Holding current value
$1.52 Million
Previous $3.02 Million 30.62%
% of portfolio
0.13%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$84.3 - $94.31 $753,136 - $842,565
-8,934 Reduced 28.22%
22,719 $2.1 Million
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $2,466 - $3,249
-34 Reduced 0.11%
31,653 $3.02 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $308 - $388
5 Added 0.02%
31,687 $2.42 Million
Q3 2023

Oct 10, 2023

BUY
$69.28 - $93.38 $131,562 - $177,328
1,899 Added 6.38%
31,682 $2.19 Million
Q2 2023

Jul 20, 2023

BUY
$81.41 - $94.33 $1.69 Million - $1.96 Million
20,792 Added 231.25%
29,783 $2.81 Million
Q1 2023

Apr 26, 2023

BUY
$74.26 - $84.51 $6,683 - $7,605
90 Added 1.01%
8,991 $743,000
Q4 2022

Jan 31, 2023

SELL
$68.3 - $87.44 $1,229 - $1,573
-18 Reduced 0.2%
8,901 $664,000
Q3 2022

Oct 18, 2022

SELL
$82.37 - $107.29 $11,284 - $14,698
-137 Reduced 1.51%
8,919 $737,000
Q2 2022

Jul 18, 2022

BUY
$86.5 - $128.27 $2,854 - $4,232
33 Added 0.37%
9,056 $861,000
Q1 2022

Apr 14, 2022

BUY
$101.96 - $128.34 $14,376 - $18,095
141 Added 1.59%
9,023 $1.06 Million
Q2 2021

Jul 16, 2021

SELL
$83.84 - $104.76 $7,629 - $9,533
-91 Reduced 1.01%
8,882 $920,000
Q1 2021

Apr 19, 2021

BUY
$78.68 - $90.67 $6,451 - $7,434
82 Added 0.92%
8,973 $751,000
Q4 2020

Jan 20, 2021

BUY
$71.69 - $91.23 $9,391 - $11,951
131 Added 1.5%
8,891 $811,000
Q2 2020

Jul 13, 2020

BUY
$57.54 - $76.95 $336,033 - $449,388
5,840 Added 200.0%
8,760 $605,000
Q3 2017

Oct 17, 2017

BUY
$36.29 - $38.83 $105,966 - $113,383
2,920
2,920 $319,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.